At a Glance
| Detail | Parambil | Steno |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | $8M | $77.5M |
| Rounds tracked | 2 | 4 |
| Latest round | Seed, $6M · Jan 2026 | Series C, $49M · Mar 2026 |
| Last valuation | Not disclosed | Not disclosed |
| Lead investors | Bling Capital, Daybreak Ventures | Savano Capital Partners, Left Lane Capital, Trust Ventures, First Round Capital |
| Built for | Mid-size firms, Boutiques | Large firms, Mid-size firms, Boutiques |
| Headquarters | United States | US |
Funding, Side by Side
Parambil rounds
- Jan 2026Seed$6M
- Jan 2025Pre-Seed$2M
Steno rounds
- Mar 2026Series C$49M
- May 2023Series B$15M
- Sep 2021Series A1$10M
- Aug 2020Seed$3.5M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Parambil or Steno?
- Steno has raised $77.5M in disclosed funding, compared with $8M for Parambil.
- Do Parambil and Steno share investors?
- No. None of the investors we track have backed both companies.
- What is Parambil best for?
- Parambil is AI medical record review software for mass tort and complex litigation.
- What is Steno best for?
- Steno provides court reporting and litigation support services, including deposition transcripts, for litigators.
Source: Legal Tech Circle funding data, from public announcements. Updated November 12, 2026.